Phase II Grant Awarded to Modulated Imaging

June 5, 2013

Modulated Imaging is excited to share that we have been awarded a Small Business Innovation Research Phase II Grant (9R44AR064657) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health (NIH). This three year, $2.2 million grant is titled “Modulated Imaging: A Wide-field Optical Imaging Platform for Clinical Research,” and will build off of the success of our Phase I Grant on the same topic. With this Phase II Grant, we will develop a research device that utilizes our innovative imaging technique, originally referred to as “modulated imaging,” but now known as Spatial Frequency Domain Imaging (SFDI).

Small Business Innovation Research Grants (SBIR) is a Congressional program coordinated by the Small Business Association, to encourage partnerships between small businesses and nonprofit research institutions. Grants are highly competitive. Proposals are judged by a team of experts, who evaluate and compare proposals on their potential impact, feasibility, and the abilities of the research team.

SFDI is a next-generation tissue imaging technology that uses visible and near-infrared light to measure blood, oxygen, melanin, and other chromophores, while also visualizing many sub-dermal structures. Unlike many other imaging systems that use potentially harmful radiation or strong magnetic fields, SFDI uses only safe light waves.

Modulated Imaging was founded to commercialize this breakthrough SFDI technology, and was spun out of the Photonic Incubator within the Beckman Laser Institute at UC Irvine. Since its inception, Modulated Imaging has been backed by a passionate team who believes in the potential of SFDI as a revolutionary tissue imaging technology for research in many fields, medical diagnostics, and therapy monitoring.